-
Kalle Gehring, PhD
… between neurodegeneration, mitochondria and the ubiquitin system. He has been studying Parkin since 2007 and has …
-
Technology for Clinicogenetic Studies of LRRK2 G2019S in Tunisia
… entry for clinical, genetic and pedigree information. This system will also support a native “Global Statistical Test” … database or datamart. Project Description: The informatics system (IS) incorporates all of the ‘clinical research …
-
Identification of a Novel Calcium Selective Antagonist for Neuroprotection in PD
… Cav1.3 calcium channels in heterologous expression systems, it is unclear whether they have the pharmacological … to determine whether when these molecules are administered systemically, they protect dopaminergic neurons against …
-
Interfering with Mitochondrial Fission to Prevent Neuronal Death in Parkinson's Disease
… addresses alterations of mitochondrial morphology in model systems of Parkinson’s disease including oxidative stress ( … insights into mechanisms of mitochondrial demise in model systems of oxidative stress-induced neuronal cell death …
-
GDNF Fusion Protein for Blood-Brain Barrier Delivery and Treatment in Parkinson's Disease
… prior attempts to treat PD patients with GDNF used a pump system that infused the GDNF directly into the brain. … antibody, which crosses the BBB via endogenous transport systems. The antibody acts as a molecular Trojan horse, and …
-
Imaging Neuroinflammation in LRRK2 Models of Parkinson’s Disease
… model and assess their long-term impact on the dopaminergic system. An optimal approach to these studies is to use … leading to the degeneration of the dopaminergic system. Such knowledge will be relevant to the understanding …